Charta Health vs Waystar (2026)
Two ways to stop a denial, aimed at different causes. Charta reviews every encounter before the bill leaves, coding from the provider's own documentation so the gap between what was written and what was billed closes while it is still cheap. Waystar runs the transaction itself at national scale, with eligibility, claim status and payment moving through infrastructure much of the provider market already touches, and an intelligence layer predicting outcomes on top. If your denials trace to documentation, Charta is upstream of them. If they trace to eligibility, submission errors and payer rules, Waystar is where that is handled. Ask Charta for the ratio of codes its review removes to codes it adds, which is what separates accuracy from optimisation.
- It reviews every encounter before the bill goes out, coding from the provider's own documentation so problems surface while they are cheap to fix.
- Tying output to what the clinician actually wrote makes the resulting claim easier to defend if it is questioned.
- For a practice whose denials come from documentation gaps, pre bill is the right intervention point.
- It runs the electronic rails at scale, with eligibility, claim status and payment transactions through infrastructure much of the provider market already touches.
- The intelligence suite sits on that platform so predictions arrive inside an existing workflow rather than as another vendor.
- For an organisation whose problem is transaction volume rather than documentation quality, that is where the leverage is.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Charta Health and Waystar are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Charta Health | Waystar |
|---|---|---|
| Primary category | Autonomous Medical Coding | RCM & Prior Auth AI |
| Founded | 2023 | Not recorded |
| Headquarters | San Francisco, California, United States | Louisville, Kentucky |
| Website | chartahealth.com | waystar.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Charta Health its top capability grade on AI Centrality and Autonomy and Oversight Model. Set against Waystar, Charta Health grades higher on AI Centrality and Autonomy and Oversight Model. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Waystar its top capability grade on several axes, including HIPAA and BAA Posture, Security Certifications and Trust Center and FDA and Regulatory Status. Set against Charta Health, Waystar grades higher on several axes, including Model Supply Chain Disclosure, HIPAA and BAA Posture and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Charta Health or Waystar?
On the axes where the AI Health Index separates them, Charta Health grades higher on AI Centrality and Autonomy and Oversight Model, and Waystar grades higher on several axes, including Model Supply Chain Disclosure, HIPAA and BAA Posture and Security Certifications and Trust Center. Waystar leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Charta Health and Waystar differ most?
The widest separation the AI Health Index records between Charta Health and Waystar is on AI Centrality, where Charta Health grades A and Waystar grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Charta Health and Waystar grade the same?
The AI Health Index grades Charta Health and Waystar the same on several axes, including Model and Technology Transparency, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
These address different causes of the same denial: one fixes what the documentation says before submission, the other manages the transaction and predicts the outcome, and an organisation with both problems needs both. Neither publishes the ratio of codes removed to codes added, which is the number that separates accuracy from optimisation on the pre bill side. Neither publishes a bias evaluation. Neither publishes pricing, and revenue cycle products are frequently priced against recovered value, which rewards volume.